Johnson & Johnson and Subsidiaries Condensed Consolidated Statement of Earnings (Unaudited; in Millions Except Per Share Figures) Percent Percent Percent Increase Amount to Sales Amount to Sales (Decrease) Sales to customers 22,321 $ 100.0 20,691 $ 100.0 7.9 Cost of products sold 7,063 31.7 7,062 34.1 0.0 Gross Profit 15,258 68.3 13,629 65.9 12.0 Selling, marketing and administrative expenses 5,432 24.3 5,203 25.1 4.4 Research and development expense 3,178 14.2 2,580 12.5 23.2 Interest (income) expense, net 48 0.2 (42) (0.2) Other (income) expense, net (882) (3.9) (679) (3.3) Restructuring 53 0.2 58 0.3 Earnings before provision for taxes on income 7,429 33.3 6,509 31.5 14.1 Provision for taxes on income 1,232 5.5 713 3.5 72.8 Net earnings 6,197 27.8 5,796 28.0 6.9 Net earnings per share (Diluted) 2.32 $ 2.17 $ 6.9 Average shares outstanding (Diluted) 2,672.7 2,671.0 Effective tax rate 16.6 % 11.0 % Adjusted earnings before provision for taxes and net earnings (1) Earnings before provision for taxes on income 8,291 $ 37.1 7,244 $ 35.0 14.5 Net earnings 6,924 $ 31.0 6,154 $ 29.7 12.5 Net earnings per share (Diluted) 2.59 $ 2.30 $ 12.6 Effective tax rate 16.5 % 15.0 % (1) See Reconciliation of Non-GAAP Financial Measures. FIRST QUARTER 2021 2020 -- 1 of 1 --